Tag Archives: Pre-approval of advertisements

Pre-approval of advertisements for therapeutic goods ends on 30 June 2020.

Why remove pre-approval? Pre-approval of advertisements aimed to increase compliance with the Therapeutic Goods Advertising Code. However, it had substantial limitations. It only applied to advertisements for medicines, not medical devices, and only to those in ‘specified media’. The latter … Continue reading

Posted in Advertising | Tagged , , | Leave a comment

Independent review: Therapeutic goods advertising

In February 2018, the Hon Greg Hunt MP, Minister for Health, committed to an independent review of the impact of the new advertising measures within two years from the commencement of the Therapeutic Goods Amendment (2017 Measures No.1) Act 2018. On … Continue reading

Posted in Advertising, Medical Devices, Pharmaceutical Promotion, TGACC | Tagged , , , , , , , | Leave a comment

APHC 2018 Contested Policy: Complementary Medicines and Advertising Reform

Abstract: PHAA Workshop – Complementary medicine and advertising reform Chair: Ken Harvey Speakers: John Skerritt – Overview of MMD recommendations Alanna Rottler – Pre-approval of certain advertisements to cease Jon Wardle – Permitted indications to replace ARTG ‘free text’ Alanna … Continue reading

Posted in Complementary medicine, Education, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment